Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02359110 · ClinicalTrials.gov registry record · Phase 4

Administration of Pre-Operative Gabapentin to Patients Undergoing Laparoscopy

A Phase 4 study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
Phase 4
Development phase
112
Enrollment target

NCT02359110: Completed Phase 4 study, sponsored by Milton S. Hershey Medical Center.

NCT02359110 is a Phase 4 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 112 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02359110, a Phase 4 study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
112 participants
Enrollment target

Study Summary

The purpose of this study is to prospectively determine the influence of immediate pre-operative gabapentin administration on acute postoperative pain. The investigators hypothesize that immediate post-operative pain will be improved with pre-operative administration of gabapentin.

Primary Outcome

The NRS is a numerical scale ranging from 0-10 implemented with adults. Having no pain is rated as a 0 and the worst pain the patient could tolerate is rated as a 10.

Interventions

  • OTHER Placebo
  • DRUG Gabapentin

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2015-06
Est. Completion 2017-01
Phase Phase 4
Milton S. Hershey Medical Center

396 total trials

What the finished NCT02359110 record still lists

NCT02359110 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (78% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02359110 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02359110 about?

NCT02359110 is a clinical study titled "Administration of Pre-Operative Gabapentin to Patients Undergoing Laparoscopy". The purpose of this study is to prospectively determine the influence of immediate pre-operative gabapentin administration on acute postoperative pain. The investigators hypothesize that immediate post-operative pain will be improved with pre-operative administration of gabapentin.

What is the current status of trial NCT02359110?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2015-06. Estimated completion is 2017-01.

What interventions are being tested in trial NCT02359110?

The interventions under investigation include: Placebo (OTHER), Gabapentin (DRUG).

Who is sponsoring clinical trial NCT02359110?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02359110's enrollment target sits among peer trials

112 724th of 2000 higher than 1,275 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04511013 · 112 participants · Phase 2

    A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • NCT04551560 · 112 participants · NA

    Stress and Congestive Heart Failure

  • NCT04872166 · 112 participants · Phase 1

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

  • NCT05024773 · 112 participants · Phase 3

    Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02359110, the US trial registry maintained by the National Library of Medicine. NCT02359110 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.